Omega Healthcare Investors, Inc. $OHI Shares Sold by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. lessened its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 19.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,848 shares of the real estate investment trust’s stock after selling 2,681 shares during the period. PNC Financial Services Group Inc.’s holdings in Omega Healthcare Investors were worth $398,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Omega Healthcare Investors during the 2nd quarter worth about $26,000. CENTRAL TRUST Co lifted its position in Omega Healthcare Investors by 1,654.4% in the second quarter. CENTRAL TRUST Co now owns 1,000 shares of the real estate investment trust’s stock valued at $37,000 after acquiring an additional 943 shares during the last quarter. Bayforest Capital Ltd boosted its stake in Omega Healthcare Investors by 395.2% in the second quarter. Bayforest Capital Ltd now owns 1,129 shares of the real estate investment trust’s stock valued at $41,000 after acquiring an additional 901 shares in the last quarter. Cullen Frost Bankers Inc. acquired a new stake in shares of Omega Healthcare Investors during the second quarter worth about $41,000. Finally, MassMutual Private Wealth & Trust FSB lifted its holdings in shares of Omega Healthcare Investors by 562.3% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 1,828 shares of the real estate investment trust’s stock valued at $67,000 after purchasing an additional 1,552 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Performance

NYSE:OHI opened at $45.13 on Tuesday. The firm has a market cap of $13.34 billion, a price-to-earnings ratio of 27.85, a price-to-earnings-growth ratio of 1.85 and a beta of 0.69. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10. Omega Healthcare Investors, Inc. has a 1-year low of $35.04 and a 1-year high of $45.56. The firm’s fifty day moving average price is $41.88 and its 200 day moving average price is $39.83.

Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.02. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The business had revenue of $311.59 million for the quarter, compared to the consensus estimate of $262.48 million. During the same quarter in the previous year, the firm earned $0.71 earnings per share. The business’s quarterly revenue was up 14.4% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.080-3.100 EPS. On average, sell-side analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, November 17th. Stockholders of record on Monday, November 3rd were paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 5.9%. The ex-dividend date of this dividend was Monday, November 3rd. Omega Healthcare Investors’s dividend payout ratio is 149.72%.

Insider Activity at Omega Healthcare Investors

In other Omega Healthcare Investors news, CEO C Taylor Pickett purchased 20,000 shares of Omega Healthcare Investors stock in a transaction dated Wednesday, November 5th. The stock was acquired at an average cost of $43.14 per share, with a total value of $862,800.00. Following the acquisition, the chief executive officer directly owned 20,000 shares of the company’s stock, valued at $862,800. This represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CIO Vikas Gupta acquired 11,500 shares of the company’s stock in a transaction that occurred on Thursday, November 6th. The shares were acquired at an average cost of $42.97 per share, for a total transaction of $494,155.00. Following the acquisition, the executive directly owned 13,773 shares of the company’s stock, valued at $591,825.81. This trade represents a 505.94% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 1.50% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on the company. Wells Fargo & Company boosted their price objective on Omega Healthcare Investors from $44.00 to $45.00 and gave the company an “overweight” rating in a research note on Tuesday, October 21st. Truist Financial increased their price target on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the stock a “hold” rating in a research note on Wednesday, September 3rd. Royal Bank Of Canada increased their price target on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 6th. Cantor Fitzgerald began coverage on shares of Omega Healthcare Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $50.00 price objective on the stock. Finally, Mizuho upped their target price on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a “neutral” rating in a report on Thursday, September 11th. Seven investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $45.89.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.